Skip to main content
. 2013 Aug 24;29(1):250–254. doi: 10.1007/s11606-013-2588-9

Table 1.

Laboratory Investigations Performed in Our Patient with Insulin Autoimmune Syndrome (IAS)

Analyte Patient Result Reference Range
During a spontaneous episode of symptomatic hypoglycemia
 Serum glucose 2.5 mmol/L (45 mg/dL) 3.6–7.8 mmol/L
 β-hydroxybutyrate < 0.30 mmol/L (< 3.1 mg/dL) < 0.30 mmol/L
 Insulin 54,930 pmol/L (7,909 μIU/mL) < 10 pmol/L when glucose ≤ 2.7 mmol/L
 C-peptide 4,104 pmol/L (12.4 ng/mL) 230–990 pmol/L
 Insulin/C-peptide molar ratio 13.4 < 1
Selective arterial calcium stimulation test
 Insulin (all specimens) > 34,000 pmol/L (> 4,895 μIU/mL)
 C-peptide (all specimens) > 5,000 pmol/L (> 15 ng/mL)
Other laboratory test results
 Liver function Unremarkable
 Kidney function Unremarkable
 Hemoglobin A1c 5.4 % 4.8–6.2 %
 ACTH stimulation test Adequate cortisol response
 Heterophile antibodies Negative
 Insulin autoantibodies > 50 kU/L (> 50 U/mL) < 0.4 kU/L
 Rheumatoid factor < 30 IU/mL < 30 IU/mL
 Antinuclear antibodies Negative
 Serum protein electrophoresis No paraprotein detected